Wall Street Zen Upgrades ENDRA Life Sciences (NASDAQ:NDRA) to Hold
ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report issued on Friday. Separately, Ascendiant Capital Markets decreased their price objective on ENDRA Life Sciences from $75.00 to $50.00 and set a “buy” rating for the company in a research report […]
ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “hold” rating in a report issued on Friday. Separately, Ascendiant Capital Markets decreased their price objective on ENDRA Life Sciences from $75.00 to $50.00 and set a “buy” rating for the company in a research report […]
